CRISPR Hits Another Snag; But It’s Two Steps Forward, One Step Back
![](https://www.mcalindenresearchpartners.com/wp-content/uploads/2018/06/41124064215_9f57737a59_o-1024x683.jpg)
Market reaction to a report that cells edited with CRISPR technology can activate a cancer-causing gene has been severe for…
McAlinden Research PartnersJune 13, 2018